| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T20 |
0-305 |
Sentence |
denotes |
Invasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. |
| T21 |
306-607 |
Sentence |
denotes |
Patients at the highest risk of invasive aspergillosis (IA) include those undergoing intensive chemotherapy for acute leukemia (AL) or recipients of allogeneic cell transplantation (alloHCT) who develop severe graft-versus-host disease, for whom antifungal prophylaxis is currently recommended [2, 3]. |
| T22 |
608-727 |
Sentence |
denotes |
With changing treatment modalities, new risk groups continue to emerge, such as patients treated with ibrutinib [4, 5]. |
